Andrew Kress

Trustee

Andrew is the CEO and founder of HealthVerity, a company providing novel technologies and tools that serve as the foundation for the rapid creation, exchange and management of healthcare and consumer data in a fully-interoperable, privacy-protecting manner.

Prior to founding HealthVerity, Andrew was the SVP of Healthcare Value Solutions for IMS Health. Among the organizations reporting to Andrew were Health Economics and Outcomes Research Services, Real World Evidence Solutions, Payer and Provider Services, Clinical Trial Optimization Solutions, and Government Services. In addition, he created the company’s mobile health offerings and designed their emerging genomics strategy. Preceding IMS, Andrew was the CEO of SDI Health—the recognized leader in clinical and transactional healthcare data-based analytics—prior to its acquisition by IMS Health in 2011. During his tenure, SDI developed and grew one of the largest linked de-identified healthcare data assets available and became the nation’s second largest pharmaceutical informatics company.

Andrew is also involved as an investor and advisor to a number of other healthcare startups. He holds a BA in English from Yale University.

About PAFA

Founded in 1805, the Pennsylvania Academy of the Fine Arts is the United States’ first school and museum of fine arts. A recipient of the National Medal of Arts, PAFA offers a world-class collection of American art, innovative exhibitions of historic and contemporary American art, and educational opportunities in the fine arts. The PAFA Museum aims to tell America's diverse story through art, expanding who has been included in the canon of art history through its collections, exhibitions, and public programs, while classes educate artists and appreciators with a deep understanding of traditions and the ability to challenge conventions. PAFA’s esteemed alumni include Mary Cassatt, Njideka Akunyili Crosby, William Glackens, Barkley L. Hendricks, Violet Oakley, Louis Kahn, David Lynch, and Henry Ossawa Tanner.